Drug interactions between omeprazole and antihypertensive medications
Pro Research Analysisby 
Searched over 200M research papers
Omeprazole and Antihypertensive Drug Interactions: Focus on Amlodipine
Omeprazole and Amlodipine: Cytochrome P450-Mediated Interactions
Omeprazole is mainly metabolized by the liver enzymes CYP2C19 and CYP3A, while amlodipine, a common antihypertensive calcium channel blocker, is primarily metabolized by CYP3A. Because both drugs share the CYP3A pathway, taking them together can lead to drug-drug interactions that may affect blood pressure control, especially in patients with both hypertension and acid-related disorders 123.
Enhanced Antihypertensive Effect with Co-Administration
Multiple studies have shown that when omeprazole is added to long-term amlodipine therapy, there is a significantly greater reduction in blood pressure compared to amlodipine alone. This effect is particularly noticeable in patients who are intermediate metabolizers (IMs) for the CYP2C19 enzyme. These patients experienced a more pronounced decrease in both systolic and diastolic blood pressure, as measured by both office and ambulatory monitoring 123. The likely reason is that omeprazole and amlodipine compete for the same metabolic pathway (CYP3A4), which may increase the blood levels and effect of amlodipine 123.
Clinical Implications for Patients with Hypertension and Acid-Related Disorders
For patients who have both hypertension and acid-related diseases, the combination of omeprazole and amlodipine is common. Research indicates that this combination can enhance the blood pressure-lowering effect of amlodipine, which may require closer monitoring and possible adjustment of antihypertensive therapy to avoid excessive drops in blood pressure .
Omeprazole and Other Cardiovascular Medications
While the main focus of the available research is on amlodipine, omeprazole has also been shown to interact with other cardiovascular drugs. For example, omeprazole can increase the levels of statin lactones (inactive forms of statins like atorvastatin), which is associated with a higher risk of major adverse cardiovascular events over five years . However, omeprazole does not appear to have a clinically significant interaction with omecamtiv mecarbil, a heart failure medication, based on pharmacokinetic studies .
Conclusion
Omeprazole can interact with antihypertensive medications, especially amlodipine, by enhancing its blood pressure-lowering effect through shared metabolic pathways. This interaction is most significant in patients with certain genetic profiles (CYP2C19 intermediate metabolizers). Clinicians should be aware of this potential interaction and monitor blood pressure closely when these drugs are used together. Omeprazole may also interact with other cardiovascular drugs, such as statins, but not all heart medications are affected.
Sources and full results
Most relevant research papers on this topic